Controversial Approval of New Drug to Treat Alzheimer's Disease

Am J Nurs. 2021 Oct 1;121(10):22-23. doi: 10.1097/01.NAJ.0000794244.40800.99.ABSTRACTAducanumab (Aduhelm), the first new drug to treat Alzheimer's disease since 2003, has received accelerated approval from the Food and Drug Administration (FDA).This drug's approval has been highly contentious in the medical and scientific community owing to contradictory study findings and the FDA's advisory panel not recommending its approval.PMID:34554982 | DOI:10.1097/01.NAJ.0000794244.40800.99
Source: The American Journal of Nursing - Category: Nursing Authors: Source Type: research